The market will be ‘fat and flat’ in the near-term according to one Goldman analyst, but this is how investors can play it.
Read MoreThe coronavirus has thrown a wrench in this year’s back-to-school season, but these 2 stocks could still see a boost as students prep for a new school year.
Read More1 stock in the retail sector looks poised to break higher.
Read MoreExperts say these 2 gold stocks may be the best way to take advantage of the metal’s climb higher.
Read MoreBuy Price: $105 or better Sell Price: TradersPro Sell Signal MyoKardia, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases. Its lead product candidate is mavacamten, an orally administered small molecule, which is in Phase III clinical trial that is designed to […]
Read MorePlus, weekly jobless claims hit their lowest level in the pandemic era but still came in above 1 million, White House and congressional Democratic negotiators have a self-imposed deadline of Friday to come to agreement on a relief package, and Bausch Health is spinning off is eye care business.
Read More“Coronavirus exhaustion” may not be a real term – but I do believe it’s a real thing. There seems to be a real sense of exhaustion about the pandemic that is contributing to a number of factors in the United States – including, to some degree, the market’s seeming resilience and resistance over the last […]
Read More